Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9

Journal of Immunology

Volumn 188, Issue 9, 2012, Pages 4690-4700

  Miyazaki, Keiko ^a   Sakuma, Keiichiro ^a,b   Kawamura, Yuki I ^c   Izawa, Mineko ^b   Ohmori, Katsuyuki ^d   Mitsuki, Motoaki ^e   Yamaji, Toshiyuki ^e   Hashimoto, Yasuhiro ^e   Suzuki, Akemi ^e   Saito, Yukio ^c   Dohi, Taeko ^c   Kannagi, Reiji ^a,b,c,f  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e RIKEN   (Japan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CD89 ANTIGEN; CYCLOOXYGENASE 2; GLYCAN; PROSTAGLANDIN E2; RECEPTOR; SIGLEC 7; SIGLEC 9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LAMINA PROPRIA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LECTINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; OLIGOSACCHARIDES; STROMAL CELLS;

EID: 84860348346     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100605     Document Type: Article

References (37)

1. Liu, F. T., and G. A. Rabinovich. 2010. Galectins: regulators of acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1183: 158-182.
2. Crocker, P. R., J. C. Paulson, and A. Varki. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7: 255-266. (Pubitemid 46480955)
3. Kannagi, R. 2002. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr. Opin. Struct. Biol. 12: 599-608. (Pubitemid 35449067)
4. Hakomori, S. 2002. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99: 10231-10233.
5. Kannagi, R., K. Sakuma, K. Miyazaki, K.-T. Lim, A. Yusa, J. Yin, and M. Izawa. 2010. Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: clues in the ongoing search for new tumor markers. Cancer Sci. 101: 586-593.
6. Kannagi, R., J. Yin, K. Miyazaki, and M. Izawa. 2008. Current relevance of incomplete synthesis and neo-synthesis for cancer-associated alteration of carbohydrate determinants - Hakomori's concepts revisited. Biochim. Biophys. Acta 1780: 525-531. (Pubitemid 351381253)
7. Miyazaki, K., K. Ohmori, M. Izawa, T. Koike, K. Kumamoto, K. Furukawa, T. Ando, M. Kiso, T. Yamaji, Y. Hashimoto, et al. 2004. Loss of disialyl Lewis (a), the ligand for lymphocyte inhibitory receptor sialic-binding immunoglobulin-like lectin 7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res. 64: 4498-4505. (Pubitemid 38856921)
8. Varki, A., and T. Angata. 2006. Siglecs - the major subfamily of I-type lectins. Glycobiology 16: 1R-27R. (Pubitemid 43009801)
9. Wang, D., and R. N. DuBois. 2008. Pro-inflammatory prostaglandins and progression of colorectal cancer. Cancer Lett. 267: 197-203.
10. Taketo, M. M. 2006. Mouse models of gastrointestinal tumors. Cancer Sci. 97: 355-361.
11. Taketo, M. M. 2006. Wnt signaling and gastrointestinal tumorigenesis in mouse models. Oncogene 25: 7522-7530. (Pubitemid 44885751)
12. Izawa, M., K. Kumamoto, C. Mitsuoka, C. Kanamori, A. Kanamori, K. Ohmori, H. Ishida, S. Nakamura, K. Kurata-Miura, K. Sasaki, et al. 2000. Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res. 60: 1410-1416. (Pubitemid 30152015)
13. Kannagi, R., A. Kitahara, S. Itai, K. Zenita, K. Shigeta, T. Tachikawa, A. Noda, H. Hirano, M. Abe, S. Shin, et al. 1988. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. Cancer Res. 48: 3856-3863.
14. Mitsuoka, C., M. Sawada-Kasugai, K. Ando-Furui, M. Izawa, H. Nakanishi, S. Nakamura, H. Ishida, M. Kiso, and R. Kannagi. 1998. Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X. J. Biol. Chem. 273: 11225-11233. (Pubitemid 28204974)
15. Kimura, N., C. Mitsuoka, A. Kanamori, N. Hiraiwa, K. Uchimura, T. Muramatsu, T. Tamatani, G. S. Kansas, and R. Kannagi. 1999. Reconstitution of functional L-selectin ligands on a cultured human endothelial cell line by cotransfection of α1->3 fucosyltransferase VII and newly cloned GlcNAcbeta:6-sulfotransferase cDNA. Proc. Natl. Acad. Sci. USA 96: 4530-4535. (Pubitemid 29190370)
16. Yamaji, T., T. Teranishi, M. S. Alphey, P. R. Crocker, and Y. Hashimoto. 2002. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to a 2,8-disialyl and branched a 2,6-sialyl residues. A comparison with Siglec-9. J. Biol. Chem. 277: 6324-6332. (Pubitemid 34968425)
17. Kannagi, R. 2000. Monoclonal anti-glycosphingolipid antibodies. Methods Enzymol. 312: 160-179.
18. Ohmori, K., K. Kanda, C. Mitsuoka, A. Kanamori, K. Kurata-Miura, K. Sasaki, T. Nishi, T. Tamatani, and R. Kannagi. 2000. P- and E-selectins recognize sialyl 6-sulfo Lewis X, the recently identified L-selectin ligand. Biochem. Biophys. Res. Commun. 278: 90-96.
19. Ohmori, K., F. Fukui, M. Kiso, T. Imai, O. Yoshie, H. Hasegawa, K. Matsushima, and R. Kannagi. 2006. Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skinhoming helper memory T cells. Blood 107: 3197-3204.
20. Takada, A., K. Ohmori, T. Yoneda, K. Tsuyuoka, A. Hasegawa, M. Kiso, and R. Kannagi. 1993. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53: 354-361. (Pubitemid 23031849)
21. Yamaji, T., M. Mitsuki, T. Teranishi, and Y. Hashimoto. 2005. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs. Glycobiology 15: 667-676. (Pubitemid 41417985)
22. Barbieri, S. S., S. Eligini, M. Brambilla, E. Tremoli, and S. Colli. 2003. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc. Res. 60: 187-197. (Pubitemid 38373491)
23. Tanji, K., T. Imaizumi, T. Matsumiya, H. Itaya, K. Fujimoto, X. Cui, T. Toki, E. Ito, H. Yoshida, K. Wakabayashi, and K. Satoh. 2001. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim. Biophys. Acta 1530: 227-235. (Pubitemid 32182432)
24. Inoue, H., and T. Tanabe. 1998. Transcriptional role of the nuclear factor k B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem. Biophys. Res. Commun. 244: 143-148. (Pubitemid 28419914)
25. Itai, S., J. Nishikata, T. Yoneda, K. Ohmori, H. Yamabe, S. Arii, T. Tobe, and R. Kannagi. 1991. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer 67: 1576-1587.
26. Kimura, N., K. Ohmori, K. Miyazaki, M. Izawa, Y. Matsuzaki, Y. Yasuda, H. Takematsu, Y. Kozutsumi, A. Moriyama, and R. Kannagi. 2007. Human B-lymphocytes express a2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J. Biol. Chem. 282: 32200-32207. (Pubitemid 350106438)
27. Smith, P. D., L. E. Smythies, M. Mosteller-Barnum, D. A. Sibley, M. W. Russell, M. Merger, M. T. Sellers, J. M. Orenstein, T. Shimada, M. F. Graham, and H. Kubagawa. 2001. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167: 2651-2656. (Pubitemid 32768894)
28. Rogler, G., M. Hausmann, D. Vogl, E. Aschenbrenner, T. Andus, W. Falk, R. Andreesen, J. Schölmerich, and V. Gross. 1998. Isolation and phenotypic characterization of colonic macrophages. Clin. Exp. Immunol. 112: 205-215. (Pubitemid 28266678)
29. Bamba, H., S. Ota, A. Kato, A. Adachi, S. Itoyama, and F. Matsuzaki. 1999. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int. J. Cancer 83: 470-475. (Pubitemid 29489860)
30. Kim, Y. S., and G. Deng. 2008. Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation. Gastroenterology 135: 305-309. (Pubitemid 351899050)
31. Kawamura, Y. I., M. Toyota, R. Kawashima, T. Hagiwara, H. Suzuki, K. Imai, Y. Shinomura, T. Tokino, R. Kannagi, and T. Dohi. 2008. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. Gastroenterology 135: 142-151.e3.
32. Nguyen, D. H., N. Hurtado-Ziola, P. Gagneux, and A. Varki. 2006. Loss of Siglec expression on T lymphocytes during human evolution. Proc. Natl. Acad. Sci. USA 103: 7765-7770.
33. McGhee, J. R., J. Kunisawa, and H. Kiyono. 2007. Gut lymphocyte migration: we are halfway 'home'. Trends Immunol. 28: 150-153. (Pubitemid 46467515)
34. Falco, M., R. Biassoni, C. Bottino, M. Vitale, S. Sivori, R. Augugliaro, L. Moretta, and A. Moretta. 1999. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 190: 793-802.
35. Nicoll, G., J. Ni, D. Liu, P. Klenerman, J. Munday, S. Dubock, M. G. Mattei, and P. R. Crocker. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 274: 34089-34095. (Pubitemid 129511743)
36. Zhang, J. Q., G. Nicoll, C. Jones, and P. R. Crocker. 2000. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 275: 22121-22126. (Pubitemid 30621792)
37. Angata, T., and A. Varki. 2000. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 275: 22127-22135. (Pubitemid 30621793)